08-31-2023
USD/share | |
Price | 64.53 |
Dividend | 0.00 |
Earnings | 1.63 |
Cash-flow | 4.36 |
Book value | 19.55 |
Equity | 18.31 |
Incyte is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Incyte is a company from USA, and his stocks are publicly traded.
Incyte stock dividend
Incyte paid a total dividend of 0 million USD last year, for a market value of 14,390 millions (Market Cap 11,869 millions). Incyte dividend per share is 0.00 USD, and his stock market price 64.53 USD.
According to the chart below where dividend yield is displayed, Incyte, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from USA, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Incyte might harm the evolution of share price if the company is not clearly expanding his business.
In addition, you should compare Incyte stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best USA dividend stocks list.
Incyte Dividend Payout
About the ability of Incyte to maintain his current dividend of USD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Incyte payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.
The following figure shows payout ratios over earnings and cashflow of Incyte, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Incyte Dividend History
Below you will find a table with the historical evolution of Incyte's dividend stock, both in percentage and in USD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | USD | Paypout | Shares* |
Present | 0.00% | 0.00 | 0.00% | 223 |
2022 | 0.00% | 0.00 | 0.00% | 222 |
2021 | 0.00% | 0.00 | 0.00% | 220 |
2020 | 0.00% | 0.00 | 0.00% | 217 |
2019 | 0.00% | 0.00 | 0.00% | 214 |
2018 | 0.00% | 0.00 | 0.00% | 212 |
2017 | 0.00% | 0.00 | 0.00% | 211 |
2016 | 0.00% | 0.00 | 0.00% | 188 |
2015 | 0.00% | 0.00 | 0.00% | 179 |
*In millions
Then you can see the evolution of Incyte dividend stock, and compare it with the average of USA stocks and that of the Pharmaceuticals and Biotechnology stocks.
Incyte Stock performance
Finally, last moth Incyte showed a return of 1.30% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -8.40% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.